Eisai to launch digital tool to assess brain health

Japan based company Eisai will launch "NouKNOWTM" (pronounced "NOH-NOH"), a new digital tool (non-medical device) for se...

March 24, 2020 | Tuesday | News
Gifu University, Astellas to create new treatments for bacterial infections

Japan based Gifu University and Astellas Pharma Inc. have announced that the parties have established, inside Gifu Unive...

March 23, 2020 | Monday | News
Eppendorf acquires centrifuge biz of Koki Holdings

Eppendorf AG and Koki Holdings Co., Ltd., have reached an agreement that Eppendorf will acquire Koki’s centri...

March 20, 2020 | Friday | News
Japan approves Novartis' SMA drug

Novartis Pharma has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved Zolgensma (o...

March 19, 2020 | Thursday | News
Fujifilm invests $83M to expand microbial production capacity

Japan based FUJIFILM Corporation has announced that it will invest approximately 9 billion yen ($83M USD)...

March 19, 2020 | Thursday | News
Ribomic inks license agreement with Aju Pharma for AMD drug

Japan based RIBOMIC Inc., a clinical stage pharmaceutical company specializing in aptamer therapeutics has signed the li...

March 18, 2020 | Wednesday | News
Japan develops new strategy to treat oral cancer

Researchers at Okayama University in Japan have recently published a study in Cells in which they reduced the ...

March 17, 2020 | Tuesday | News
Heartseed collaborates with Itochu Chemical Frontier

Heartseed, a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for the treatment of heart failure...

March 13, 2020 | Friday | News
Japan to test AIM ImmunoTech’s Ampligen for COVID-19

AIM ImmunoTech, an immunopharmaceutical company focused on the development of immunological, viral and multiple cancer t...

March 10, 2020 | Tuesday | News
Nagase Medicals, Osaka University to work on drug delivery systems

NAGASE & CO., LTD. (NAGASE) and Osaka University have launched DDS Products Joint Development Research Cha...

March 6, 2020 | Friday | News
Takeda initiates development of Plasma-Derived Therapy for COVID-19

Japan based Takeda Pharmaceutical Company will share with members of the United States Congress that it is initiating th...

March 5, 2020 | Thursday | News
Saki Corporation opens new factory in Japan

Japan based Saki Corporation, an innovator in the field of automated optical and X-ray inspection equipment, announces t...

March 4, 2020 | Wednesday | News
Takeda to divest select assets to Hypera for $825M

Japan based Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest a p...

March 3, 2020 | Tuesday | News
UCB, Daiichi Sankyo to offer new treatment option for epilepsy

UCB Japan Co., Ltd, and Daiichi Sankyo Company, Limited are pleased to announce that a supplemental application for VIMP...

March 2, 2020 | Monday | News
Takeda acquires PvP Biologics focusing on celiac disease treatment

Japan based Takeda Pharmaceutical Company Limited announced that it has acquired US based PvP Biologics, Inc. follo...

February 28, 2020 | Friday | News
Eisai, FUJI YAKUHIN to work on hyperuricemia and gout treatment

Japan based Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD.  have concluded a license agreement concerning dotinurad (ge...

February 27, 2020 | Thursday | News
Softbank leads $165 M funding for Karius

Japanese multinational conglomerate holding company SoftBank Group led the new funding round for US based firm...

February 26, 2020 | Wednesday | News
Eisai receives recognition for contribution towards liver diseases

Japan based pharmaceutical firm Eisai announced that it has received the President’s Award at the 8th Technology M...

February 25, 2020 | Tuesday | News